Pharmacokinetics of two formulations of alendronate sodium/cholecalciferol (vitamin D₃) tablets 70 mg/5600 IU: An open-label, randomized, single-dose, two-treatment, two-period, two-sequence, cross-over, bioequivalence study

By Tippabhotla Sudhakar Koundinya   Thota Satyanarayana   Khan Sohel Md.   Gadiko Chaitanya   Yergude Sandeep   Cheerla Raju   Nakkawar Mukesh   Betha Madhava Rao   Battula Ramakrishna   Vobalaboina Venkateswarlu  

Clinical Research and Regulatory Affairs, Vol. 30, Iss. 1-2, 2013-03 ,pp. : 14-22

Informa Healthcare

Access to resources Recommend Favorite

Alendronate: An Update of its Use in Osteoporosis

By Sharpe M.   Noble S.   Spencer C.M.  

Drugs, Vol. 61, Iss. 7, 2001-01 ,pp. : 999-1039

Adis International

Access to resources Recommend Favorite

Effects of amines on percutaneous absorption of alendronate

By Whang Jiae   Gwak Hyesun  

Drug Development and Industrial Pharmacy, Vol. 37, Iss. 5, 2011-05 ,pp. : 491-497

Informa Healthcare

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Alendronate in the Treatment of Involutional Osteoporosis

By Devogelaer J-P.  

Drug Safety, Vol. 19, Iss. 2, 1998-08 ,pp. : 141-154

Adis International

Access to resources Recommend Favorite

Update on alendronate for osteoporosis: once-weekly dosing

By Schnitzer Thomas J  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 9, 2001-09 ,pp. : 1461-1472

Informa Healthcare

Access to resources Recommend Favorite